<
Shaanxi Institute of Traditional Chinese Medicine、The New Drug Technology Development Center held a 2013 scientific research stake online sports bettingstake betting appproject summary report meeting
Release time: 2014-01-06     Source: Anonymous

    December 27, 2013,In the conference room on the fifth floor of the group R&D center,Shaanxi Institute of Traditional Chinese Medicine was held、New Drug Technology Development Center 2013 Scientific Research stake online sports bettingstake betting appproject summary report Meeting,The meeting was chaired by Director Xiao Zhiqiang,Attending the meeting was Zhang Jian, chief pharmacist of the group company、Shan Zhifeng, Manager of the Technology Department of the Group Company,Institute、Members of the New Drug Center team and all scientific researchers,Specially invited&ldquo to the meeting;Three Qin Scholars”Professor Wang Siwang、“Hundred Talents Plan”Professor Bu Xin provides on-site guidance。

    On the basis of summarizing Stake Sports Bettingstake betting appthe work in 2013,The person in charge of each project reported on the research progress achieved by the project、Existing technical problems and next work plan were reported in detail,And answered questions from experts。

    Professor Wang Siwang and Professor Bu Xin made detailed comments on the research ideas and project implementation of each project one by one,Guided on site,And put forward pertinent suggestions on how to improve in the next step。

    Meeting,Manager Shan Zhifeng approves the project、Conduct mid-term project evaluation、Proposed requirements to strengthen scientific research risk control by introducing an exit mechanism。

    Last,Pharmacist Zhang gave a speech,Fully affirmed the results achieved by the two scientific research units in the past year,Affirmed the positive effect of the reporting meeting on improving the Stake Sports Bettingstake sports betting appcomprehensive quality of scientific researchers,Requesting solutions to the problems raised by experts as soon as possible,Further clarify R&D goals,Reduce R&D risks,Improving the success rate of new drug research and development,Produce more results for the group,Results coming soon,Produce good results and contribute。